The Out-of-State Prescriber and the Schedule II

This requires analysis of both the prescriber's authority and the prescription's form.

Prescriber authority:

• A physician licensed in Alabama is not licensed to practice medicine in Florida. However, Florida recognizes prescriptions written by out-of-state prescribers in limited circumstances. Under Florida law, a prescription for a controlled substance written by a prescriber licensed in another state may be filled in Florida only if the prescriber is authorized to prescribe in his or her own state and the prescription meets Florida's requirements. But Florida has specific limits: a prescriber not licensed in Florida may not prescribe Schedule II controlled substances for a patient in Florida except in narrow exceptions (e.g., a prescriber treating a patient in a hospital or hospice setting, or an out-of-state prescriber who is registered with the state under applicable rules). A routine outpatient Schedule II prescription from an Alabama physician for a Florida visitor is generally not fillable.
• Additionally, the prescriber must have a valid DEA registration in the state where the prescription is issued; the DEA registration state must match the prescriber's practice location. An Alabama DEA registration does not authorize prescribing in Florida.

Prescription form:

• Florida requires Schedule II prescriptions to be written on a security prescription form meeting Florida's specifications (or transmitted electronically per Florida's e-prescribing rules). The form here is a Florida-style form, but the prescriber is an Alabama physician. The form alone does not cure the prescriber's lack of Florida authority.
• The prescription is 3 days old, within the 7-day limit for Schedule II fills, but that does not resolve the authority issue.

Conclusion: Dr. Patel should not fill the prescription as written. She should explain to the patient why, and advise the patient to contact her Alabama prescriber, who may be able to arrange a transfer to a Florida-licensed prescriber or provide an alternative. Dr. Patel should document the refusal and the reason.

If the prescription were otherwise valid and Dr. Patel filled it (which the analysis above says she should not), the following would apply:

Recordkeeping:

• Schedule II prescriptions must be maintained in a separate file or readily retrievable, and the pharmacy must keep records for at least 2 years (Florida requires 2 years for prescription records; federal DEA requires 2 years as well).
• The pharmacist must verify the prescription's validity, including the prescriber's DEA number and state licensure.
• The dispensing must be reported to Florida's PDMP (E-FORCSE) as required by Florida law; reporting is generally required within 24 hours of dispensing.

PDMP obligations:

• Dr. Patel must consult the PDMP before dispensing a controlled substance. She has done so and found no Florida fills - which is not necessarily exculpatory, since the patient may have filled in Alabama.
• She should consider checking the Alabama PDMP if available, or asking the patient for permission to contact the Alabama prescriber.

Red flags:

• Out-of-state prescriber, out-of-state patient, no Florida fill history, Schedule II opioid, high quantity (120 tablets), and a prescriber who cannot be reached. These are classic indicators of potential diversion or doctor-shopping.
• The patient's explanation ('forgot her medication') is plausible but unverified.
• The pain management agreement from Alabama does not substitute for Florida prescriber authority.

Correct action: Refuse to fill, document the refusal and the reasons, and advise the patient to seek a Florida-licensed prescriber or have her Alabama prescriber arrange continuity of care through a Florida pharmacy with a Florida-licensed prescriber.